Skip to main content
Journal cover image

Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT

Publication ,  Conference
Martin, PL; Driscoll, TA; Szabolcs, P; Parikh, SH; Prasad, VK; Kurtzberg, J
Published in: Biology of Blood and Marrow Transplantation
February 2006

Duke Scholars

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2006

Volume

12

Issue

2

Start / End Page

127 / 127

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Martin, P. L., Driscoll, T. A., Szabolcs, P., Parikh, S. H., Prasad, V. K., & Kurtzberg, J. (2006). Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT. In Biology of Blood and Marrow Transplantation (Vol. 12, pp. 127–127). Elsevier BV. https://doi.org/10.1016/j.bbmt.2005.11.389
Martin, P. L., T. A. Driscoll, P. Szabolcs, S. H. Parikh, V. K. Prasad, and J. Kurtzberg. “Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT.” In Biology of Blood and Marrow Transplantation, 12:127–127. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.389.
Martin PL, Driscoll TA, Szabolcs P, Parikh SH, Prasad VK, Kurtzberg J. Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 127–127.
Martin, P. L., et al. “Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT.” Biology of Blood and Marrow Transplantation, vol. 12, no. 2, Elsevier BV, 2006, pp. 127–127. Crossref, doi:10.1016/j.bbmt.2005.11.389.
Martin PL, Driscoll TA, Szabolcs P, Parikh SH, Prasad VK, Kurtzberg J. Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT. Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 127–127.
Journal cover image

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2006

Volume

12

Issue

2

Start / End Page

127 / 127

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences